Dual or Mono Antiplatelet Therapy for the Prevention of Ischemic Stroke: A Literature Review (original) (raw)
Dual Antiplatelet Therapy Role in Acute Ischemic Stroke
Dr. Marjan Assefi
Journal of Critical Care & Emergency Medicine
View PDFchevron_right
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibility
Philip M Bath
PloS one, 2008
View PDFchevron_right
Dual or Mono Antiplatelet Therapy for Patients With Acute Ischemic Stroke or Transient Ischemic Attack
Philip Bath
Stroke, 2012
View PDFchevron_right
Antiplatelet therapy in secondary stroke prevention
Robert Talbert
Expert Opinion on Pharmacotherapy, 2001
View PDFchevron_right
Combination aspirin and clopidogrel for secondary prevention of ischemic stroke
Oscar Alvarez Benavente
2013
View PDFchevron_right
Safety and Efficacy of Intensive vs. Guideline Antiplatelet Therapy in High-Risk Patients with Recent Ischemic Stroke or Transient Ischemic Attack: Rationale and Design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) Trial (ISRCTN47823388)
Philip M Bath
International Journal of Stroke, 2015
View PDFchevron_right
Antiplatelets in Stroke Prevention
Antonio Pinto
Current Vascular Pharmacology, 2014
View PDFchevron_right
Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack
Philip Bath
Circulation, 2013
View PDFchevron_right
Triple antiplatelet therapy for secondary prevention of recurrent ischemic stroke
Philip M Bath
View PDFchevron_right
Trends in Usage of Alternative Antiplatelet Therapy After Stroke and Transient Ischemic Attack
Nancy Hills
Stroke, 2008
View PDFchevron_right
Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
Soudeh Ghafouri-Fard
Clinical and Translational Medicine
View PDFchevron_right
Clopidogrel and Aspirin in Acute Ischemic Stroke and High-Risk TIA
William Barsan
The New England journal of medicine, 2018
View PDFchevron_right
EARLY antiplatelet treatment after ischaemic stroke
Harold Adams
The Lancet Neurology, 2010
View PDFchevron_right
Recent Clinical Trial Results with Antiplatelet Therapy: Implications in Stroke Prevention
Philip Teal
Cerebrovascular Diseases, 2004
View PDFchevron_right
Different Antiplatelet Strategies in Patients With New Ischemic Stroke While Taking Aspirin
Hee-Joon Bae
Stroke; a journal of cerebral circulation, 2015
View PDFchevron_right
Comparison of antiplatelet regimens in secondary stroke prevention: a nationwide cohort study
Jannik Pallisgaard
BMC Neurology, 2015
View PDFchevron_right
Antiplatelet Effect of Aspirin in Ischemic Stroke: A Hospital-based Study
Yookarin Khonglah
Journal of Advances in Medicine and Medical Research
View PDFchevron_right
Antiplatelet treatment for acute secondary prevention of non-cardioembolic minor stroke / transient ischaemic attack: an update for the acute physician
Philip M Bath
Clinical Medicine
View PDFchevron_right
Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT
Philip M Bath
Health technology assessment (Winchester, England), 2018
View PDFchevron_right
Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack: An Updated Systematic Review and Meta-Analysis
Philip M Bath
Circulation, 2013
View PDFchevron_right
Balancing Benefits and Risks of Long-Term Antiplatelet Therapy in Noncardioembolic Transient Ischemic Attack or Stroke
Jacoba Greving
Stroke, 2021
View PDFchevron_right
Evaluation of Antiplatelet Agents for Secondary Prevention of Stroke Using Mixed Treatment Comparison Meta-analysis
Jennifer Donovan, Matthew Silva
Clinical Therapeutics, 2013
View PDFchevron_right
Baseline characteristics of the 3096 patients recruited into the 'Triple Antiplatelets for Reducing Dependency after Ischemic Stroke' trial
Philip M Bath
International journal of stroke : official journal of the International Stroke Society, 2016
View PDFchevron_right
Characterization of Ischemic Events and Use of Prescription Antiplatelet and Anticoagulant Agents After Stroke or Transient Ischemic Attack
Hemal Shah
Journal of Stroke and Cerebrovascular Diseases, 2005
View PDFchevron_right
Antiplatelet Therapy After Noncardioembolic Stroke
Philip Bath
Stroke, 2019
View PDFchevron_right
Efficacy versus safety: the dilemma of using novel platelet inhibitors for the treatment of patients with ischemic stroke and coronary artery disease
Gianmarco Iannopollo, Rita Camporotondo
Therapeutics and Clinical Risk Management, 2014
View PDFchevron_right
Comparative Effectiveness of Aspirin and Clopidogrel Versus Aspirin in Acute Minor Stroke or Transient Ischemic Attack
Hee-Joon Bae
Stroke
View PDFchevron_right
Effectiveness of Platelet Function Analysis-Guided Aspirin and/or Clopidogrel Therapy in Preventing Secondary Stroke: A Systematic Review and Meta-Analysis
Reza Mortazavi
View PDFchevron_right
LOADING CLOPIDOGREL IN THE MANGEMENT OF ACUTE ISCHEMIC STROKE: CASE PRESENTATIONSH.M. Aref, N.M. Nahas, M. Awad, Ain Shams University, Cairo, Egypt Cerebrovascular diseases
Hany Aref
View PDFchevron_right
RETRACTED ARTICLE: Dual versus mono antiplatelet therapy for acute non- cardio embolic ischemic stroke or transient ischemic attack, an efficacy and safety analysis - updated meta-analysis
Federick Cheng
BMC Neurology, 2020
View PDFchevron_right
Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischaemia (TARDIS): a randomised, open-label, phase 3 superiority trial
Philip M Bath
Lancet (London, England), 2017
View PDFchevron_right